11-Deoxycorticosterone Producing Adrenal Hyperplasia as a Very Unusual Cause of Endocrine Hypertension

11-deoxycorticosterone overproduction due to an adrenal tumor or hyperplasia is a very rare cause of mineralocorticoid-induced hypertension. The objective is to provide the most relevant clinical features that clinicians dealing with patients presenting with the hallmarks of hypertension due to 11-d...

Descripción completa

Detalles Bibliográficos
Autores: Asla Roca, Queralt|||0000-0001-6049-8048, Sardà, Helena|||0000-0002-0138-8217, Lerma Puertas, Enrique|||0000-0001-7908-2747, Hanzu, Felicia A.|||0000-0002-2399-4023, Rodrigo, María Teresa, Urgell, Eulàlia|||0000-0003-3519-1022, Pérez, José Ignacio, Webb, S. M.|||0000-0001-7052-6436, Aulinas, Anna|||0000-0002-1205-7114
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:258086
Acceso en línea:https://ddd.uab.cat/record/258086
https://dx.doi.org/urn:doi:10.3389/fendo.2022.846865
Access Level:acceso abierto
Palabra clave:Mineralocorticoid hypertension
Mineralocorticoid excess
11-deoxycorticosterone (DOC)
DOC-producing adrenal tumor
Adrenal hyperplasia
Adrenocortical carcinoma
Adrenal adenoma
Descripción
Sumario:11-deoxycorticosterone overproduction due to an adrenal tumor or hyperplasia is a very rare cause of mineralocorticoid-induced hypertension. The objective is to provide the most relevant clinical features that clinicians dealing with patients presenting with the hallmarks of hypertension due to 11-deoxycorticosterone-producing adrenal lesions should be aware of. We report the case of a patient with an 11-deoxycorticosterone-producing adrenal lesion and provide a systematic review of all published cases (PubMed, Web of Science and EMBASE) between 1965 and 2021. We identified 46 cases (including ours). Most cases (31, 67%) affected women with a mean age of 42.9 ± 15.2 years and presented with high blood pressure and hypokalemia (average of 2.68 ± 0.62 mmol/L). Median (interquartile range) time from onset of first suggestive symptoms to diagnosis was 24 (55) months. Aldosterone levels were low or in the reference range in 98% of the cases when available. 11-deoxycorticosterone levels were a median of 12.5 (18.9) times above the upper limit of the normal reference range reported in each article and overproduction of more than one hormone was seen in 31 (67%). Carcinoma was the most common histological type (21, 45.7%). Median tumor size was 61.5 (60) mm. Malignant lesions were larger, had higher 11-deoxycorticosterone levels and shorter time of evolution at diagnosis compared to benign lesions. 11-deoxycorticosterone-producing adrenal lesions are very rare, affecting mostly middle-aged women with a primary aldosteronism-like clinical presentation and carcinoma is the most frequent histological diagnosis. Measuring 11-deoxycorticosterone levels, when low aldosterone levels or in the lower limit of the reference range are present in hypertensive patients, is advisable. Open Science Framework.